Hercules Capital appoints Pam Randhawa to board, effective Nov 1, 2021

Hercules Capital, Inc.

Ms. Randhawa will serve as a Class I director with term expiring in 2023.
She will serve on the Nominating and Corporate Governance Committee.
She brings over 20 years of healthcare/life sciences experience; currently CEO/Founder of Empiriko Corporation.
She will receive standard director compensation including annual retainer and restricted stock awards.

item 5.02 item 8.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Pam Randhawa

director

HTGC · Hercules Capital, Inc.

Effective: 2021-11-01
Filed: October 20, 2021, 7:59 PM ET

On October 20, 2021, the Board of Directors of the Company appointed Pam Randhawa as a director of the Company, effective November 1, 2021.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Pam Randhawa was appointed as director at Hercules Capital, Inc..

Action: appointed
Role: director

Exact text from the filing

On October 20, 2021, the Board of Directors of the Company appointed Pam Randhawa as a director of the Company, effective November 1, 2021.

View on SEC.gov

Hercules Capital, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-21-302630

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.